Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Obstetrics and Gynecology
|
May 21, 2026
Prenatal Cell-Free DNA Screening With Fetal Fraction Amplification at 6-9 Weeks of Gestation
Lorraine Dugoff, Brent Mabey, Jhett Bordwell, et al.
JCO Precision Oncology
|
January 12, 2023
Cancer Risk Associated With <i>PTEN</i> Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
Shelly Cummings, Andrew Alfonso, Elisha Hughes, et al.
Cancer Genetics
|
October 15, 2023
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants
Erin Mundt, Brent Mabey, Irene Rainville, et al.
Prenatal Diagnosis
|
April 16, 2024
High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification
Carly Hammer, Summer Pierson, Ashley Acevedo, et al.
Journal of the National Cancer Institute
|
April 21, 2022
Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes
Anna Gardiner, John Kidd, Maria C Elias, et al.
Plos One
|
May 6, 2024
External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis
Eric H Sasso, Brent Mabey, Darl D Flake, et al.
Urologic Oncology
|
December 1, 2020
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer
David S Morris, J Scott Woods, Byard Edwards, et al.
Frontiers in Pharmacology
|
November 17, 2025
Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
Daniel Hain, Andria L Del Tredici, Ryan B Griggs, et al.
Arthritis Research & Therapy
|
December 5, 2020
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
Jeffrey R Curtis, Fenglong Xie, Cynthia S Crowson, et al.
Personalized Medicine
|
September 11, 2020
Clinical validity of a gene expression signature in diagnostically uncertain neoplasms
Loren E Clarke, Brent Mabey, Darl D Flake Ii, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Obstetrics and Gynecology
|
May 21, 2026
Prenatal Cell-Free DNA Screening With Fetal Fraction Amplification at 6-9 Weeks of Gestation
Lorraine Dugoff, Brent Mabey, Jhett Bordwell, et al.
JCO Precision Oncology
|
January 12, 2023
Cancer Risk Associated With <i>PTEN</i> Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
Shelly Cummings, Andrew Alfonso, Elisha Hughes, et al.
Cancer Genetics
|
October 15, 2023
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants
Erin Mundt, Brent Mabey, Irene Rainville, et al.
Prenatal Diagnosis
|
April 16, 2024
High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification
Carly Hammer, Summer Pierson, Ashley Acevedo, et al.
Journal of the National Cancer Institute
|
April 21, 2022
Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes
Anna Gardiner, John Kidd, Maria C Elias, et al.
Plos One
|
May 6, 2024
External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis
Eric H Sasso, Brent Mabey, Darl D Flake, et al.
Urologic Oncology
|
December 1, 2020
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer
David S Morris, J Scott Woods, Byard Edwards, et al.
Frontiers in Pharmacology
|
November 17, 2025
Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
Daniel Hain, Andria L Del Tredici, Ryan B Griggs, et al.
Arthritis Research & Therapy
|
December 5, 2020
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
Jeffrey R Curtis, Fenglong Xie, Cynthia S Crowson, et al.
Personalized Medicine
|
September 11, 2020
Clinical validity of a gene expression signature in diagnostically uncertain neoplasms
Loren E Clarke, Brent Mabey, Darl D Flake Ii, et al.
Page
of 2